AI Maverick Intel, Inc. (AIMV)
OTCMKTS
· Delayed Price · Currency is USD
0.0750
-0.0150 (-16.67%)
At close: Apr 28, 2026
AI Maverick Intel Revenue
In the year 2013, AI Maverick Intel had annual revenue of $92.26K.
Revenue
92.26K
Revenue Growth
n/a
P/S Ratio
43.89
Revenue / Employee
18.45K
Employees
5
Market Cap
4.05M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADM Tronics Unlimited | 3.41M |
| Kelyniam Global | 2.67M |
| Biotricity | 15.45M |
| Ludwig Enterprises | 207.00 |
| CYduct Diagnostics | 344.78K |
| BioElectronics | 1.61M |
| REMSleep Holdings | 16.72K |
AI Maverick Intel News
- 4 weeks ago - AI Maverick Intel Announces Letter of Intent to Acquire HEAL Access Canada Inc. as Initial Transaction Under Strategic ROFR Framework - Accesswire
- 6 weeks ago - AI Maverick Intel Announces Strategic Right of First Refusal Agreement with HEAL Group - Accesswire
- 6 months ago - AI Maverick Intel, Inc. Announces New Trading Symbol “AIMV” Effective Oct. 20, 2025 - GlobeNewsWire
- 9 months ago - AI Maverick Intel Provides Corporate Update - Accesswire
- 10 months ago - AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required - Accesswire
- 11 months ago - Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval - Accesswire
- 1 year ago - Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation - Accesswire
- 1 year ago - Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit - Accesswire